Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | Y28C |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | PALB2 Y28C lies within the DNA-binding, and BRCA1 and RAD51-interacting regions of the Palb2 protein (UniProt.org). Y28C results in decreased Brca1 binding and Rad51 foci formation (PMID: 28319063, PMID: 31586400), and impaired homology-directed DNA repair activity in cultured cells in one study (PMID: 28319063, PMID: 31586400, PMID: 31757951), but results in intermediate homology-directed DNA repair in a reporter assay (PMID: 33964450), and rescues PARP inhibitor sensitivity in PALB2-null cells (PMID: 31586400), and therefore, its effect on Palb2 protein function is unknown. |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 Y28C |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23638095T>C |
| cDNA | c.83A>G |
| Protein | p.Y28C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001407300.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_024675 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_001407297.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_001407302.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| NM_001407298.1 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| XM_017023672 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| XM_017023673 | chr16:g.23638095T>C | c.83A>G | p.Y28C | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PALB2 Y28C | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, Lynparza (olaparib) treatment decreased viability of cells expressing PALB2 Y28C in culture (PMID: 31757951). | 31757951 |